Reata Pharma (RETA) Tops Q3 EPS by 67c
Tweet
Share
E-mailGet Alerts RETA Hot Sheet
Join SI Premium – FREE
Reata Pharma (NASDAQ: RETA) reported Q3 EPS of ($1.31), $0.67 better than the analyst estimate of ($1.98).
For earnings history and earnings-related data on Reata Pharma (RETA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
- Sypris Solutions (SYPR) Reports Q2 Loss of $0.14
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
